Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06840899 · ClinicalTrials.gov registry record · Phase 2
CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury
A Phase 2 study of Spinal Cord Injury and Urinary Incontinence, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06840899 is a Phase 2 study of Spinal Cord Injury and Urinary Incontinence that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 20 participants, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06840899, a Phase 2 study of Spinal Cord Injury and Urinary Incontinence, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this feasibility study is to learn whether Cannabidiol (CBD) can improve urinary incontinence and other symptoms in people with recent spinal cord injury (SCI). Participants will take Epidiolex (purified CBD) for 90 days
Conditions Studied
Interventions
- DRUG CBD
Study Locations (1)
Wisconsin
- University of Wisconsin - Madison - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-02-13 |
| Est. Completion | 2027-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06840899
The ClinicalTrials.gov registry entry for NCT06840899 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 86-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (77% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Spinal Cord Injury appearing as the primary indexed condition, and to 1 intervention - of which CBD is the first listed.
NCT06840899 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06840899 about?
NCT06840899 is a clinical study titled "CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury". The goal of this feasibility study is to learn whether Cannabidiol (CBD) can improve urinary incontinence and other symptoms in people with recent spinal cord injury (SCI). Participants will take Epidiolex (purified CBD) for 90 days
What is the current status of trial NCT06840899?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2026-02-13. Estimated completion is 2027-05.
What conditions does trial NCT06840899 study?
This clinical trial studies the following conditions: Spinal Cord Injury, Urinary Incontinence, Supra-sacral Spinal Cord Injury.
What interventions are being tested in trial NCT06840899?
The interventions under investigation include: CBD (DRUG).
Who is sponsoring clinical trial NCT06840899?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06840899 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Treating Central Neuropathic Pain With Low Dose Naltrexone for People With Spinal Cord Injury
RECRUITING · Phase 2
-
Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury
RECRUITING · Phase 2
-
Electrical Control of Bladder in Spinal Cord Injury Patients
COMPLETED · Phase 2
-
Effects of Electrical Stimulation and Vitamin D Supplementation on Bone Health Following Spinal Cord Injury.
COMPLETED · Phase 2
-
Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan/Lidocaine Combination Clinical Trial
COMPLETED · Phase 2
-
Use of an Oral Beta-2 Agonist in Persons With Spinal Cord Injury
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.